Form 4: HCA Healthcare Executive Jennifer Berres Reports Stock Transactions
SEC Form 4 Filing
Jennifer Berres, SVP & Chief Human Resources Officer at HCA Healthcare, reports the exercise of stock appreciation rights and disposition of shares to cover tax obligations.
Summary
- On February 7, 2025, Jennifer Berres, SVP & Chief Human Resources Officer of HCA Healthcare, executed transactions involving HCA's common stock.
- Berres exercised stock appreciation rights (SARs) that were granted in previous years.
- Specifically, 7,440 SARs with an exercise price of $101.16 and 4,340 SARs with an exercise price of $139.06 were exercised.
- Following the exercise of these SARs, Berres disposed of 6,747 shares of common stock at a price of $322.05 per share to satisfy tax obligations.
- After these transactions, Berres directly owns 23,764 shares of HCA Healthcare common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies like HCA Healthcare. These transactions are closely monitored by investors for insights into management's perspective on the company's performance and future prospects. Form 4 filings are a standard part of regulatory compliance.
Comparison to Industry Standards
- Executive compensation packages in the healthcare industry often include stock options and stock appreciation rights to align management's interests with those of shareholders.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize equity-based compensation as part of their overall executive pay structure.
- The vesting schedules and exercise prices of SARs are generally comparable across similar large-cap healthcare companies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may be interested in executive stock transactions as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 01/31/2019 | Start date of vesting for 7,440 stock appreciation rights in four equal annual installments. |
| 01/30/2020 | Start date of vesting for 4,340 stock appreciation rights in four equal annual installments. |
| 02/07/2025 | Date of the reported transactions: exercise of stock appreciation rights and disposition of shares. |
| 02/11/2025 | Date of signature for the Form 4 filing. |
| 01/31/2028 | Expiration date for the stock appreciation rights with exercise price of $101.16. |
| 01/30/2029 | Expiration date for the stock appreciation rights with exercise price of $139.06. |
Keywords
HCA Healthcare, Jennifer Berres, Stock Appreciation Rights, Form 4, Insider Trading, Executive Compensation, Equity Securities, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.